Skip to main content
Intermediate Technical IVT

estrogen receptor negative

Breast cancer cells lacking estrogen receptor expression, affecting hormonal therapy eligibility.

Full Definition

Estrogen receptor negative (ER-negative) describes breast cancer tumors that do not express estrogen receptors as determined by immunohistochemistry testing. Tumors are considered ER-negative when fewer than 1% of cancer cells show nuclear staining for estrogen receptor protein. This classification excludes the use of endocrine therapies such as tamoxifen or aromatase inhibitors, as these treatments target estrogen signaling pathways. ER-negative status is associated with different prognosis and treatment responses compared to ER-positive tumors.

Usage

Usage note: Hyphenate when used as compound adjective; may be abbreviated as ER- in clinical settings.

In Context

  • "Estrogen receptor negative status eliminated endocrine therapy options." — oncology consultation
  • "The tumor was estrogen receptor negative with strong HER2 expression." — molecular pathology report

Also known as

ER-negative ER-

Contrasted with

estrogen receptor positive ER-positive ER+

Don't confuse with

estrogen receptor positive progesterone receptor negative

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON